Foster Wayne has filed 17 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 108000 shares of Atea Pharmaceuticals, Inc. ($AVIR) on January 31, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 108000 | $0.00 | 108,000.0000 | 78,126,796 | 9999.99% | 0.14% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | M | Restricted Stock Units | 8000 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.01% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | M | Restricted Stock Units | 33333 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.04% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | F | Common Stock | 12132 | $4.24 | 79,329.0000 | 78,126,796 | 13.26% | 0.02% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | M | Common Stock | 41333 | $0.00 | 91,461.0000 | 78,126,796 | 82.45% | 0.05% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 120100 | $0.00 | 120,100.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | M | Common Stock | 33333 | $0.00 | 54,190.0000 | 0 | 159.82% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | A | Common Stock | 8000 | $0.00 | 62,190.0000 | 0 | 14.76% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | F | Common Stock | 12062 | $3.06 | 50,128.0000 | 0 | 19.40% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | M | Restricted Stock Units | 33333 | $0.00 | 33,333.0000 | 0 | 50.00% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | A | Restricted Stock Units | 8000 | $0.00 | 8,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 120100 | $0.00 | 120,100.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | M | Restricted Stock Units | 33334 | $0.00 | 66,666.0000 | 0 | 33.33% | 0.00% |
| Feb. 1, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | S | Common Stock | 12477 | $3.84 | 20,857.0000 | 0 | 37.43% | 0.00% |
| Jan. 31, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | M | Common Stock | 33334 | $0.00 | 33,334.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 140000 | $0.00 | 140,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Atea Pharmaceuticals, Inc. | $AVIR | Foster Wayne | EVP, Chief Accounting Officer | A | Restricted Stock Units | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |